NAIROBI (Reuters) - World Health Organization Director-General Tedros Adhanom Ghebreyesus said he was releasing an additional $2 million to support Uganda's response to its Ebola outbreak, which has killed one person and infected at least eight others.

Ugandan authorities have begun a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in the outbreak declared last week.

Amid a new Ebola outbreak in Kampala, Uganda, the World Health Organization has kicked off a vaccine trial. This is the first Ebola outbreak in the country since 2022, when cases emerged in the Mubende District. While both outbreaks involve the same virus species — Sudan Ebolavirus (SUDV) — genetic analysis confirms they’re not connected.

Confirmation of Ebola Sudan in Uganda poses a high risk of further spread owing to the index patient's movements across multiple districts and healthcare facilities, the WHO said. It added that rapid containment is critical, because of Kampala's dense population and Mbale's location near the border with Kenya.

Health authorities in Uganda say Ebola cases in the country have risen to nine while 265 other people are being monitored under quarantine.

The Ugandan health ministry has said the number of confirmed Ebola cases in the country has risen from three to nine. Recall that the East African country last month declared an outbreak of the severe,

Nine people were confirmed to have Ebola virus in Uganda and around 265 others are being monitored under quarantine, health authorities have said. The nine include the first victim, a male nurse who died the day before the outbreak was declared on January 30.